The team at WEHI, including researchers from the Parkinson's Disease Research Center, have identified a small molecule that can selectively block cell death. Published in Science Advances ...

While CAR T cell therapy—a personalized form of cancer immunotherapy first successfully developed by Carl June, MD, and his team at Penn—has revolutionized treatment for many blood cancers ...

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene therapy space, experts express wariness over the unknowns and optimism that ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares ...

Hairy-cell leukemia (HCL) is a rare, indolent neoplasm of mature B cells with hairlike surface projections that circulate in the blood and preferentially infiltrate the bone marrow and spleen.

Microbial fermentation method is not yet in production scale due to the limited microbial intracellular enzymes activities for the metabolic pathway to produced D-allulose from hexose or pentose ...

In the second part of the Tesla 4680-type cylindrical battery cell teardown and analysis, The Limiting Factor presents the initial specs and findings. While the teardown video was very interesting ...

This flow cell has a confined wall-jet design and consists of a gold ... epimers (galactose and glucose); (4) hexose (fructose) or pentose (arabinose) for monosaccharides; and (5) deoxy sugars (fucose ...

Finally, we used the Golgi-IP method to show that loss of the UDP-galactose transporter SLC35A2 (19, 20) leads to depletion of UDP-hexose specifically in the Golgi while its levels in the whole cell ...